Quarterly Result9 May 2026, 02:00 pm
Advanced Enzyme Tech Recommends ₹1.35 Dividend for FY26
AI Summary
Advanced Enzyme Technologies Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. A final dividend of ₹1.35 per equity share (67.5%) has been recommended, subject to shareholder approval. The board also approved the reappointment of Mr. Mukund Madhusudan Kabra as Whole Time Director and the appointment of Mr. Pradip Bhailal Shah as an Additional Director (Independent). Additionally, MSKA & Associates LLP were reappointed as Statutory Auditors. The company also approved the allotment of 49,350 Equity Shares under ESOP 2022.
Key Highlights
- Final dividend of ₹1.35 per share (67.5%) recommended for FY26, pending shareholder approval.
- Mukund Madhusudan Kabra re-appointed as Whole Time Director for 5 years from April 1, 2027.
- Pradip Bhailal Shah appointed as Additional Director (Independent) effective June 12, 2026.
- MSKA & Associates LLP reappointed as Statutory Auditors for five years.
- 49,350 Equity Shares allotted under Employees Stock Options Scheme 2022.
Price Impact
More from ADVENZYMES